$25.74
-0.09-0.35%
Ult. Agg.: Oct 28, 4:46 PM
Avalyn Pharma (AVLN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.98 | $-0.66 | -48.5 % |
| Q1 | Jun 3, 2026 | $-21.83 | $-16.38 | -33.3 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.66 | $-16.38 |
| Actual | $-0.98 | $-21.83 |
| Surprise | -48.5% | -33.3% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.73 | $-0.71 |
| Revenue | ||
| Consensus | — | — |